Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Dendritic Cell-activated Cytokine-induced Killer Cell Combined With Chemotherapy for Advanced Solid Tumor

NCT04214717 is registered in ClinicalTrials.gov with Yantai Yuhuangding Hospital as lead sponsor.

NCT NCT04214717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04214717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Dendritic Cell-activated Cytokine-induced Killer Cell Combined With Chemotherapy for Advanced Solid Tumor
Lead sponsor
Yantai Yuhuangding Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2019
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor